China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.52
(-5.59%)
USD 1.52
(-5.59%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 95.05 Million USD | 4.49% |
| 2023 | 90.97 Million USD | -14.49% |
| 2022 | 106.38 Million USD | 0.07% |
| 2021 | 106.31 Million USD | 6.83% |
| 2020 | 99.51 Million USD | 36.83% |
| 2019 | 72.73 Million USD | -1.47% |
| 2018 | 73.81 Million USD | 9.88% |
| 2017 | 67.17 Million USD | 8.22% |
| 2016 | 62.07 Million USD | 4.31% |
| 2015 | 59.5 Million USD | 29.62% |
| 2014 | 45.9 Million USD | -32.33% |
| 2013 | 67.83 Million USD | -9.5% |
| 2012 | 74.96 Million USD | 38.98% |
| 2011 | 53.93 Million USD | 123.58% |
| 2010 | 24.12 Million USD | 1501975.78% |
| 2009 | 1606.00 USD | -94.71% |
| 2008 | 30.35 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 95.05 Million USD | 0.0% |
| 2024 Q1 | 94.76 Million USD | 4.17% |
| 2024 Q3 | 95.05 Million USD | 0.31% |
| 2024 FY | 95.05 Million USD | 4.49% |
| 2024 Q2 | 94.76 Million USD | 0.0% |
| 2023 Q3 | 90.97 Million USD | -10.61% |
| 2023 FY | 90.97 Million USD | -14.49% |
| 2023 Q1 | 101.76 Million USD | -4.34% |
| 2023 Q2 | 101.76 Million USD | 0.0% |
| 2023 Q4 | 90.97 Million USD | 0.0% |
| 2022 Q1 | 116.88 Million USD | 9.95% |
| 2022 FY | 106.38 Million USD | 0.07% |
| 2022 Q4 | 106.38 Million USD | 0.0% |
| 2022 Q3 | 106.38 Million USD | -8.98% |
| 2022 Q2 | 116.88 Million USD | 0.0% |
| 2021 Q1 | 100.57 Million USD | 1.06% |
| 2021 Q3 | 102.55 Million USD | -2.78% |
| 2021 FY | 106.31 Million USD | 6.83% |
| 2021 Q2 | 105.48 Million USD | 4.88% |
| 2021 Q4 | 106.31 Million USD | 3.66% |
| 2020 Q2 | 87.14 Million USD | 8.64% |
| 2020 FY | 99.51 Million USD | 36.83% |
| 2020 Q3 | 85.79 Million USD | -1.55% |
| 2020 Q4 | 99.51 Million USD | 15.99% |
| 2020 Q1 | 80.21 Million USD | 10.29% |
| 2019 Q3 | 67.02 Million USD | 3.59% |
| 2019 Q1 | 64.57 Million USD | -12.51% |
| 2019 FY | 72.73 Million USD | -1.47% |
| 2019 Q4 | 72.73 Million USD | 8.51% |
| 2019 Q2 | 64.7 Million USD | 0.2% |
| 2018 Q2 | 70.16 Million USD | 7.33% |
| 2018 FY | 73.81 Million USD | 9.88% |
| 2018 Q4 | 73.81 Million USD | -0.38% |
| 2018 Q3 | 74.09 Million USD | 5.6% |
| 2018 Q1 | 65.37 Million USD | -2.68% |
| 2017 Q2 | 61.18 Million USD | 11.21% |
| 2017 Q1 | 55.02 Million USD | -11.36% |
| 2017 FY | 67.17 Million USD | 8.22% |
| 2017 Q4 | 67.17 Million USD | 23.75% |
| 2017 Q3 | 54.28 Million USD | -11.29% |
| 2016 Q1 | 62.53 Million USD | 5.09% |
| 2016 FY | 62.07 Million USD | 4.31% |
| 2016 Q4 | 62.07 Million USD | 3.59% |
| 2016 Q3 | 59.91 Million USD | -5.96% |
| 2016 Q2 | 63.71 Million USD | 1.88% |
| 2015 Q3 | 54.22 Million USD | 9.62% |
| 2015 Q4 | 59.5 Million USD | 9.74% |
| 2015 FY | 59.5 Million USD | 29.62% |
| 2015 Q1 | 43 Million USD | -6.32% |
| 2015 Q2 | 49.46 Million USD | 15.03% |
| 2014 Q3 | 67.48 Million USD | -3.95% |
| 2014 FY | 45.9 Million USD | -32.33% |
| 2014 Q1 | 69.63 Million USD | 2.65% |
| 2014 Q4 | 45.9 Million USD | -31.98% |
| 2014 Q2 | 70.26 Million USD | 0.9% |
| 2013 Q4 | 67.83 Million USD | -16.51% |
| 2013 FY | 67.83 Million USD | -9.5% |
| 2013 Q1 | 83.74 Million USD | 11.72% |
| 2013 Q2 | 88.24 Million USD | 5.37% |
| 2013 Q3 | 81.25 Million USD | -7.93% |
| 2012 Q3 | 66.3 Million USD | 2.82% |
| 2012 Q1 | 56.04 Million USD | 3.91% |
| 2012 Q4 | 74.96 Million USD | 13.05% |
| 2012 FY | 74.96 Million USD | 38.98% |
| 2012 Q2 | 64.48 Million USD | 15.07% |
| 2011 FY | 53.93 Million USD | 123.58% |
| 2011 Q1 | 43.36 Million USD | 79.78% |
| 2011 Q4 | 53.93 Million USD | 9.9% |
| 2011 Q3 | 49.07 Million USD | 12.45% |
| 2011 Q2 | 43.64 Million USD | 0.63% |
| 2010 Q2 | 19.7 Million USD | 2850992.47% |
| 2010 Q1 | 691.00 USD | 281.77% |
| 2010 FY | 24.12 Million USD | 1501975.78% |
| 2010 Q4 | 24.12 Million USD | 14.32% |
| 2010 Q3 | 21.1 Million USD | 7.11% |
| 2009 Q4 | 181.00 USD | 4.02% |
| 2009 Q2 | 463.00 USD | -71.17% |
| 2009 FY | 1606.00 USD | -94.71% |
| 2009 Q3 | 174.00 USD | -62.42% |
| 2009 Q1 | 1606.00 USD | -71.36% |
| 2008 Q2 | 29.49 Thousand USD | 0.0% |
| 2008 FY | 30.35 Thousand USD | 0.0% |
| 2008 Q4 | 5607.00 USD | -74.99% |
| 2008 Q3 | 22.41 Thousand USD | -24.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.25 Million USD | -1707.349% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 311.75 Million USD | 69.509% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 312.16 Million USD | 69.549% |
| Leafly Holdings, Inc. | 21.83 Million USD | -335.343% |
| LifeMD, Inc. | 58.48 Million USD | -62.544% |
| LifeMD, Inc. | 58.48 Million USD | -62.544% |
| TRxADE HEALTH, Inc. | 12.53 Million USD | -658.46% |
| PetMed Express, Inc. | 175.09 Million USD | 45.711% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | 99.883% |